TARQVARA PHARMA TECHNOLOGIES OÜ
Date of report 25.02.2026
Open the reports you want to print
Employees and salaries
TARQVARA PHARMA TECHNOLOGIES OÜ
Employee taxes and performance analysis?
| Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
|---|---|---|---|---|
| 2025 IV | ...... | ...... | ...... | ...... |
| 2025 III | ...... | ...... | ...... | ...... |
| 2025 II | ...... | ...... | ...... | ...... |
| 2025 I | ...... | ...... | ...... | ...... |
| 2024 IV | ...... | ...... | ...... | ...... |
| 2024 III | ...... | ...... | ...... | ...... |
| 2024 II | ...... | ...... | ...... | ...... |
| 2024 I | ...... | ...... | ...... | ...... |
| 2023 IV | ...... | ...... | ...... | ...... |
| 2023 III | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... |
| 2023 I | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... |
| 2022 III | ...... | ...... | ...... | ...... |
| 2022 II | ...... | ...... | ...... | ...... |
| 2022 I | ...... | ...... | ...... | ...... |
| 2021 IV | ...... | ...... | ...... | ...... |
| 2021 III | ...... | ...... | ...... | ...... |
| 2021 II | ...... | ...... | ...... | ...... |
| 2021 I | ...... | ...... | ...... | ...... |
| 2020 IV | ...... | ...... | ...... | ...... |
| 2020 III | ...... | ...... | ...... | ...... |
| 2020 II | ...... | ...... | ...... | ...... |
| 2020 I | ...... | ...... | ...... | ...... |
| 2019 IV | ...... | ...... | ...... | ...... |
| 2019 III | ...... | ...... | ...... | ...... |
| 2019 II | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
TARQVARA PHARMA TECHNOLOGIES OÜ
Decision-makers?
Alexey Khudzinskiy
★★★★
......
Credit Score: ...
Reputation score: ...
Date of birth: ......
Active relations 1
Jelena Khudzinskaya
★★★★
......
Credit Score: ...
Reputation score: ...
Date of birth: ......
Active relations 1
Ekaterina Konopleva
★★★★
......
Credit Score: ...
Reputation score: ...
Date of birth: ......
Active relations 1
*Every member of the management board may represent the private limited company in concluding all transactions.
TARQVARA PHARMA TECHNOLOGIES OÜ
History of right of representation?
Field
Administrative Activities
Business age
6y
Beneficial country:
Estonia
2019
2020
2021
2022
2023
2024
2025
2026
2019
2020
2021
2022
2023
2024
2025
2026
TARQVARA PHARMA TECHNOLOGIES OÜ
Owners?
Former owners
Beneficiaries
Volumes and values of beneficiaries' assets
Finances and assets
TARQVARA PHARMA TECHNOLOGIES OÜ ...
GoodwillTARQVARA PHARMA TECHNOLOGIES OÜ
Taxes paid and estimated average salariesTARQVARA PHARMA TECHNOLOGIES OÜ
Quarterly indicators| Quarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
|---|---|---|---|---|---|---|---|
| 2025 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2025 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2025 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2025 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
TARQVARA PHARMA TECHNOLOGIES OÜ
Sales revenue by business areaTARQVARA PHARMA TECHNOLOGIES OÜ ...
Sales revenue by countryTARQVARA PHARMA TECHNOLOGIES OÜ ...
Financial indicators and prognosisTARQVARA PHARMA TECHNOLOGIES OÜ ...
Financial raiting: "VERY GOOD" (2025 prognosis)2025 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good
TARQVARA PHARMA TECHNOLOGIES OÜ
Annual reports| Year | Period | Submitted | Report PDF |
|---|---|---|---|
| 2024 | 01.01.2024–31.12.2024 | 02.05.2025 | ...... |
| 2023 | 01.01.2023–31.12.2023 | 01.06.2024 | ...... |
| 2022 | 01.01.2022–31.12.2022 | 22.06.2023 | ...... |
| 2021 | 01.01.2021–31.12.2021 | 01.07.2022 | ...... |
| 2020 | 01.01.2020–31.12.2020 | 05.05.2021 | ...... |
| 2019 | 01.01.2019–31.12.2019 | 09.10.2020 | ...... |
Liabilities and debts
TARQVARA PHARMA TECHNOLOGIES OÜ
Credit score history and prognosisRecommended credit limit
... €
Recommended payment term
......
Business risk classes:
Trustworthy Neutral
Borderline
Problematic
Risky
TARQVARA PHARMA TECHNOLOGIES OÜ
Reports and assets-liabilities overview 25.02.2026?
Annual reports:
......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €
TARQVARA PHARMA TECHNOLOGIES OÜ
Claims history?
Debt claims as of ......
Total debt claims: ...... €
PAYMENT SCHEDULE
......Latest events
| ...... | ...... |
TARQVARA PHARMA TECHNOLOGIES OÜ
Debt by type 24.02.2026?
| Type of claim | Amount of claims | In repayment schedule | Disputed | Management board during which the debt was incurred | Representative |
|---|---|---|---|---|---|
| Tax collector 's claims | ...... € | ...... € | ...... € | ||
| Special income tax | ...... € | ...... € | ...... € | ETCB | |
| Social tax | ...... € | ...... € | ...... € | ETCB | |
| Withholding tax | ...... € | ...... € | ...... € | ETCB | |
| Creditors' claims | ...... € | ...... € | ...... € | ||
| Total | ...... € | ...... € | ...... € |
TARQVARA PHARMA TECHNOLOGIES OÜ
Time-barred and ongoing claims as of 24.02.2026?
Ongoing
Sum:
Sum:
......
...... €
...... €
Time-barred
Sum:
Sum:
......
...... €
...... €
TARQVARA PHARMA TECHNOLOGIES OÜ
Income (turnover) and expenditure (taxes paid)?
| Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
|---|---|---|---|---|---|
| 2025 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2025 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2025 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2025 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 II | * ...... € | ...... € | ...... € | ...... € | ...... |
TARQVARA PHARMA TECHNOLOGIES OÜ
Bailiff's enforcement proceedings as of 25.02.2026?
Bailiff's enforcement proceedings MISSING
TARQVARA PHARMA TECHNOLOGIES OÜ
Regulations of the Payment Order Department as of 25.02.2026?
Regulations of the Payment Order Department MISSING
TARQVARA PHARMA TECHNOLOGIES OÜ
Court orders in the register as of 25.02.2026?
Court order MISSING
TARQVARA PHARMA TECHNOLOGIES OÜ
Decisions of the Consumer Disputes Committee as of 25.02.2026?
Consumer disputes MISSING
TARQVARA PHARMA TECHNOLOGIES OÜ
Court hearings as of 25.02.2026?
Court hearings MISSING
TARQVARA PHARMA TECHNOLOGIES OÜ
Rulings as of 25.02.2026?
Court settlemets MISSING
TARQVARA PHARMA TECHNOLOGIES OÜ
Notices and announcements as of 25.02.2026?
Announcements MISSING
Marketing
Business network
TARQVARA PHARMA TECHNOLOGIES OÜ
Business networkCREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired
Beneficiaries network
TARQVARA PHARMA TECHNOLOGIES OÜ
Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events found.
Failed to load monitoring events.